Evidence map›Paper›PMID 39826002›Full record

ArticleAnnals of nuclear medicine2025

Utility of

Guoying Zhang, Jie Shen, Tianpeng Hu, Wei Zheng, Qiang Jia, Jian Tan, Zhaowei Meng

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guoying ZhangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Jie ShenDepartment of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, 300192, China.
Tianpeng HuDepartment of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, 300192, China.
Wei ZhengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Qiang JiaDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Jian TanDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Zhaowei MengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China. zmeng@tmu.edu.cn.ORCID http://orcid.org/0000-0001-6370-7394

Funding

National Natural Science Foundation of China grants 81571709National Natural Science Foundation of China grants 81971650Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-001ATianjin Science and Technology Committee Foundation grant 21JCYBJC01060Tianjin Science and Technology Committee Foundation grant 21JCYBJC01820
6 · The paper itself

Abstract

objectiveUsing

methods

resultsThere were 42 ND-PTLD patients, 7 P-PTLD patients, and 14 M-PTLD patients. Ki-67 was significantly correlated with all metabolic parameters (P all < 0.01). SUVmean, SUVmax, MTV, TLG and GTV were all highest in M-PTLD, followed by P-PTLD, ND-PTLD, and RLH. ROC curves showed

conclusion

Indexed as

Fluorodeoxyglucose F18Lymphoproliferative DisordersPositron Emission Tomography Computed TomographyAdolescentAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesROC CurveYoung AdultFluorodeoxyglucose F1818F-FDG PET/CTDiagnostic efficacyMetabolic parametersPTLD

Identifiers

PMID39826002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.